{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2015:FHL2NXZ66XUYTZJ7YRZMQPHV6G","short_pith_number":"pith:FHL2NXZ6","canonical_record":{"source":{"id":"1503.09149","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.PE","submitted_at":"2015-03-31T18:09:28Z","cross_cats_sorted":[],"title_canon_sha256":"c62112b53561a2ef7ae5b05c1b07fe6d188ad5b498c170d187ca3fc45fa17f60","abstract_canon_sha256":"0e9e05600ca6269138494985e8c33250e346b5ec0de1c0ff85fa635fc665d23d"},"schema_version":"1.0"},"canonical_sha256":"29d7a6df3ef5e989e53fc472c83cf5f189981b6b3a0767ac659b616d416531c0","source":{"kind":"arxiv","id":"1503.09149","version":1},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1503.09149","created_at":"2026-05-18T02:19:51Z"},{"alias_kind":"arxiv_version","alias_value":"1503.09149v1","created_at":"2026-05-18T02:19:51Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1503.09149","created_at":"2026-05-18T02:19:51Z"},{"alias_kind":"pith_short_12","alias_value":"FHL2NXZ66XUY","created_at":"2026-05-18T12:29:19Z"},{"alias_kind":"pith_short_16","alias_value":"FHL2NXZ66XUYTZJ7","created_at":"2026-05-18T12:29:19Z"},{"alias_kind":"pith_short_8","alias_value":"FHL2NXZ6","created_at":"2026-05-18T12:29:19Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2015:FHL2NXZ66XUYTZJ7YRZMQPHV6G","target":"record","payload":{"canonical_record":{"source":{"id":"1503.09149","kind":"arxiv","version":1},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.PE","submitted_at":"2015-03-31T18:09:28Z","cross_cats_sorted":[],"title_canon_sha256":"c62112b53561a2ef7ae5b05c1b07fe6d188ad5b498c170d187ca3fc45fa17f60","abstract_canon_sha256":"0e9e05600ca6269138494985e8c33250e346b5ec0de1c0ff85fa635fc665d23d"},"schema_version":"1.0"},"canonical_sha256":"29d7a6df3ef5e989e53fc472c83cf5f189981b6b3a0767ac659b616d416531c0","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T02:19:51.287705Z","signature_b64":"i5i4I38AezMT6nEFA67udo9zM2hx1EtQ0LReWHLiXIO3exk4GVRS6KLImpRfr5rgPFW/GGfiPs53VTFmdB1hCQ==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"29d7a6df3ef5e989e53fc472c83cf5f189981b6b3a0767ac659b616d416531c0","last_reissued_at":"2026-05-18T02:19:51.287011Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T02:19:51.287011Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1503.09149","source_version":1,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T02:19:51Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"URR2uI260jks5dlJBVqquXsI/H9zpsla4064T+Xa7eWOqeBqFRim/F0V+HA0EknA8wgFL9aX/qdl5U78WRC/Cg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-07T12:04:44.333111Z"},"content_sha256":"f8ead80fcb75d0bb36cca025ef893e188f415fd8aeae2d695264470ede766850","schema_version":"1.0","event_id":"sha256:f8ead80fcb75d0bb36cca025ef893e188f415fd8aeae2d695264470ede766850"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2015:FHL2NXZ66XUYTZJ7YRZMQPHV6G","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":[],"primary_cat":"q-bio.PE","authors_text":"Edward A. Wenger, Jaline Gerardin, Philip Eckhoff","submitted_at":"2015-03-31T18:09:28Z","abstract_excerpt":"Antimalarial drugs are a powerful tool for malaria control and elimination. Artemisinin-based combination therapies (ACTs) can reduce transmission when widely distributed in a campaign setting. Modelling mass antimalarial campaigns can elucidate how to most effectively deploy drug-based interventions and quantitatively compare the effects of cure, prophylaxis, and transmission-blocking in suppressing parasite prevalence. A previously established agent-based model that includes innate and adaptive immunity was used to simulate malaria infections and transmission. Pharmacokinetics of artemether,"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1503.09149","kind":"arxiv","version":1},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T02:19:51Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"jk+JY4142jKosj+K1wQ/xWNpsuvVXorHGs7YvTdUzEueCu9Ayj4MBFJfQjkVNwrlFTuJKjBgjtw3V+A3kX0EAg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-06-07T12:04:44.333706Z"},"content_sha256":"2eae04da5bed8c353846fc87c17bd15130fdaa47b1b600159283a4eb0ffa38c2","schema_version":"1.0","event_id":"sha256:2eae04da5bed8c353846fc87c17bd15130fdaa47b1b600159283a4eb0ffa38c2"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/FHL2NXZ66XUYTZJ7YRZMQPHV6G/bundle.json","state_url":"https://pith.science/pith/FHL2NXZ66XUYTZJ7YRZMQPHV6G/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/FHL2NXZ66XUYTZJ7YRZMQPHV6G/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-06-07T12:04:44Z","links":{"resolver":"https://pith.science/pith/FHL2NXZ66XUYTZJ7YRZMQPHV6G","bundle":"https://pith.science/pith/FHL2NXZ66XUYTZJ7YRZMQPHV6G/bundle.json","state":"https://pith.science/pith/FHL2NXZ66XUYTZJ7YRZMQPHV6G/state.json","well_known_bundle":"https://pith.science/.well-known/pith/FHL2NXZ66XUYTZJ7YRZMQPHV6G/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2015:FHL2NXZ66XUYTZJ7YRZMQPHV6G","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"0e9e05600ca6269138494985e8c33250e346b5ec0de1c0ff85fa635fc665d23d","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.PE","submitted_at":"2015-03-31T18:09:28Z","title_canon_sha256":"c62112b53561a2ef7ae5b05c1b07fe6d188ad5b498c170d187ca3fc45fa17f60"},"schema_version":"1.0","source":{"id":"1503.09149","kind":"arxiv","version":1}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1503.09149","created_at":"2026-05-18T02:19:51Z"},{"alias_kind":"arxiv_version","alias_value":"1503.09149v1","created_at":"2026-05-18T02:19:51Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1503.09149","created_at":"2026-05-18T02:19:51Z"},{"alias_kind":"pith_short_12","alias_value":"FHL2NXZ66XUY","created_at":"2026-05-18T12:29:19Z"},{"alias_kind":"pith_short_16","alias_value":"FHL2NXZ66XUYTZJ7","created_at":"2026-05-18T12:29:19Z"},{"alias_kind":"pith_short_8","alias_value":"FHL2NXZ6","created_at":"2026-05-18T12:29:19Z"}],"graph_snapshots":[{"event_id":"sha256:2eae04da5bed8c353846fc87c17bd15130fdaa47b1b600159283a4eb0ffa38c2","target":"graph","created_at":"2026-05-18T02:19:51Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"Antimalarial drugs are a powerful tool for malaria control and elimination. Artemisinin-based combination therapies (ACTs) can reduce transmission when widely distributed in a campaign setting. Modelling mass antimalarial campaigns can elucidate how to most effectively deploy drug-based interventions and quantitatively compare the effects of cure, prophylaxis, and transmission-blocking in suppressing parasite prevalence. A previously established agent-based model that includes innate and adaptive immunity was used to simulate malaria infections and transmission. Pharmacokinetics of artemether,","authors_text":"Edward A. Wenger, Jaline Gerardin, Philip Eckhoff","cross_cats":[],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.PE","submitted_at":"2015-03-31T18:09:28Z","title":"Mass campaigns with antimalarial drugs: a modelling comparison of artemether-lumefantrine and DHA-piperaquine with and without primaquine as tools for malaria control and elimination"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1503.09149","kind":"arxiv","version":1},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:f8ead80fcb75d0bb36cca025ef893e188f415fd8aeae2d695264470ede766850","target":"record","created_at":"2026-05-18T02:19:51Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"0e9e05600ca6269138494985e8c33250e346b5ec0de1c0ff85fa635fc665d23d","cross_cats_sorted":[],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"q-bio.PE","submitted_at":"2015-03-31T18:09:28Z","title_canon_sha256":"c62112b53561a2ef7ae5b05c1b07fe6d188ad5b498c170d187ca3fc45fa17f60"},"schema_version":"1.0","source":{"id":"1503.09149","kind":"arxiv","version":1}},"canonical_sha256":"29d7a6df3ef5e989e53fc472c83cf5f189981b6b3a0767ac659b616d416531c0","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"29d7a6df3ef5e989e53fc472c83cf5f189981b6b3a0767ac659b616d416531c0","first_computed_at":"2026-05-18T02:19:51.287011Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T02:19:51.287011Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"i5i4I38AezMT6nEFA67udo9zM2hx1EtQ0LReWHLiXIO3exk4GVRS6KLImpRfr5rgPFW/GGfiPs53VTFmdB1hCQ==","signature_status":"signed_v1","signed_at":"2026-05-18T02:19:51.287705Z","signed_message":"canonical_sha256_bytes"},"source_id":"1503.09149","source_kind":"arxiv","source_version":1}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:f8ead80fcb75d0bb36cca025ef893e188f415fd8aeae2d695264470ede766850","sha256:2eae04da5bed8c353846fc87c17bd15130fdaa47b1b600159283a4eb0ffa38c2"],"state_sha256":"67a1ad5d03b8798bfc8874d99cdfab2a4d1d4257ac1289049af24bd0b6e758e4"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"TTdPZXkO1jV2FvpV7h7LnLF0aGlN6HFKS2gKcJPNeW+J3yEPB7h4DVkQCOiRhO2f1ZxfPLLoFQJacbqyuritDQ==","signed_message":"bundle_sha256_bytes","signed_at":"2026-06-07T12:04:44.339560Z","bundle_sha256":"988d23a80db5ec5857d6ec26eba6f18d12419996773a158b6f3f1bec63920c38"}}